{
    "clinical_study": {
        "@rank": "79000", 
        "arm_group": {
            "arm_group_label": "ED chest pain presenting patients"
        }, 
        "brief_summary": {
            "textblock": "1. In chest pain patients with suspected acute coronary syndrome, a 2-hr delta Troponin-I\n           as measured by the i-STAT immunoassay reliably identifies and excludes an acute\n           myocardial infarction.\n\n        2. In chest pain patients with suspected acute coronary syndrome whose baseline troponin\n           is above the 99th percentile but less than 0.2ng/ml, a 2hr delta Troponin-I as measured\n           by the i-STAT immunoassay accurately discriminates between acute myocardial infarction\n           and non-acute myocardial infarction troponin elevations."
        }, 
        "brief_title": "Usefulness of a 2-hour Delta Troponin-I During the ED Identification and Exclusion of Acute Myocardial Infarction", 
        "completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Acute Coronary Syndrome", 
        "condition_browse": {
            "mesh_term": [
                "Infarction", 
                "Myocardial Infarction", 
                "Acute Coronary Syndrome"
            ]
        }, 
        "detailed_description": {
            "textblock": "Primary Aims: 1) Demonstrate that a 2hr delta troponin as measured by the i-STAT platform\n      can reliably identify and exclude MI on the initial ED evaluation. 2)Demonstrate that a 2hr\n      delta troponin is useful in the discrimination AMI versus non-AMI conditions in patients\n      with low abnormal baseline Troponin-I values.\n\n      Secondary Aims: 1) Demonstrate that a positive 2-hr delta troponin-I identifies patients at\n      highest risk for 30 day ACE. 2) Other Secondary aims TBD."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Adult patients 18 years of age or older\n\n          2. Chest pain suspicious for ACS\n\n          3. Absence of ST-segment elevation AMI (STEMI) or STEMI equivalent on the initial ECG\n\n          4. Baseline i-STAT troponin less or equal to 1.0 ng/ml\n\n          5. Enrollment initiated before 2 hour 'delt' troponin value available for review\n\n          6. Ability and willingness to participate and cooperate with telephone follow-up\n             evaluations\n\n        Exclusion Criteria:\n\n          1. ST-elevation or other ECG criteria that results in the diagnosis of AMI and results\n             in patient being sent for percutaneous coronary interventions (PCI) or being treated\n             with thrombolytics\n\n          2. Patients with chest pain not deemed to warrant cardiac screening\n\n          3. Blunt chest trauma\n\n          4. Tachyarrhythmia (ventricular tachycardia, supraventricular tachycardia, or rapid\n             atrial fibrillation)\n\n          5. Cardiac Arrest prior to arrival\n\n          6. Hemodynamically unstable patients\n\n          7. Pulmonary edema requiring CPAP, BIPAP, or mechanical ventilation\n\n          8. Baseline i-STAT troponin measurement greater than 1.0 ng/ml\n\n          9. Baseline and 2-hour i-STAT Troponin measurements not obtained\n\n         10. Patient (or Legal Representative) unable or unwilling to provide written informed\n             consent\n\n         11. Subject unwilling or unlikely to comply with study procedures, including\n             protocol-specific blood sampling\n\n         12. Subject unwilling, unable, or deemed unlikely to respond or participate in telephone\n             follow-up\n\n         13. Vulnerable populations as deemed inappropriate for the study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Adult patients presenting to the Emergency Department with chest pain or similar symptoms,\n        and risk factors for ACS."
            }
        }, 
        "enrollment": {
            "#text": "1000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 2, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02002546", 
            "org_study_id": "IRB# 13-069"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Heart Attack", 
            "Myocardial Infarction", 
            "Angina", 
            "Chest Pain"
        ], 
        "lastchanged_date": "February 5, 2014", 
        "location": {
            "contact": {
                "email": "donna.carroll2@erlanger.org", 
                "last_name": "Donna J Carroll, Associates in Nursing", 
                "phone": "423-778-3903"
            }, 
            "contact_backup": {
                "email": "lakina.campbell@erlanger.org", 
                "last_name": "Lakina Campbell", 
                "phone": "423-778-3902"
            }, 
            "facility": {
                "address": {
                    "city": "Chattanooga", 
                    "country": "United States", 
                    "state": "Tennessee", 
                    "zip": "37403"
                }, 
                "name": "Erlanger Baroness Medical Center"
            }, 
            "investigator": [
                {
                    "last_name": "Harry W Severance, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Ron C Buchheit, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Robert L Huang, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Sudave Mendiratta, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Usefulness of a 2-hour Delta Troponin-I During the ED Identification and Exclusion of Acute Myocardial Infarction", 
        "overall_contact": {
            "email": "donna.carroll2@erlanger.org", 
            "last_name": "Donna J Carroll, Associate", 
            "phone": "423-778-3903"
        }, 
        "overall_contact_backup": {
            "email": "lakina.campbell@erlanger.org", 
            "last_name": "Lakina Campbell, Master's", 
            "phone": "423-778-3902"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change in Troponin value over a two hour interval.", 
            "safety_issue": "Yes", 
            "time_frame": "2 hours after baseline"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02002546"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Chattanooga-Hamilton County Hospital Authority", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Chattanooga-Hamilton County Hospital Authority", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "February 2014"
    }
}